Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Laura_Durrant
    Junior Member
    • Nov 2023
    • 1

    #1

    Switching from Illumina to Element Biosciences

    Hi everyone,

    Like most genomics core facilities, we are always looking for ways of providing the most optimal and cost-effective NGS solutions for our service users. In an attempt to do so, we recently took the bold decision to swap out our long trusted Illumina NextSeq 500 instrument with a new Element Biosciences AVITI sequencer. We have never used an AVITI before so this is completely new and slightly scary territory for us.

    Has anyone else made this transition from Illumina to Element? And if so, do you have any advice that you can share? Or perhaps any nuances/key differences you may have come across in the prep, run set up and primary/secondary data analysis compared to Illumina?

    Many thanks and happy sequencing!

    Laura Durrant
    Genomics Facility, Babraham Institute

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Today, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
67 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
47 views
0 reactions
Last Post SEQadmin2  
Working...